Real Questions from Real Subscribers


Q: Under the title of "Company (price; ticker)" -- Is the price listed the BUY price or the price the stock was when the table was made? If it is the price when the table was made, which I think it is, do you have a BUY PRICE like some other papers?


A: Dear Subscriber,

When you see a reference to a stock price, either in the text or in a table, it almost always refers to the price at the time of publication. We don't use target prices; a stock is either a Buy or it is not. We'll never tell you to buy XYZ when it dips to $10 or sell when it reaches $20. When we no longer believe a stock represents a good investment, we'll downgrade it in the newsletter, or on our biweekly hotlines.

Thanks for your interest,

Bob Sweet, CFA
Managing Editor, Dow Theory Forecasts

More Investment Newsletters and Services

Drip Investor

DRIP Investor — how you can buy dividend-paying stocks without a broker.

Visit us at DRIP Investor, your source for dividend reinvestment plans.

Lazy Investor

The Lazy Investor — free weekly e-letter that delivers market updates and stock market information via email.

Visit us at The Lazy Investor, our free investment newsletter.

Horizon Investment

Horizon — registered investment advisor seeks to provide investors at all stages the ability to build, preserve and enjoy wealth.

Visit us at Horizon Investment Services to get started in an investment program that's right for you.

Upside

Upside — discovers today's small and midcap stocks poised to be tomorrow's Blue Chip leaders.

Visit us at Upside, your guide to the best buys in small and midcap stocks.

Current Hotline

Friday, June 14, 2013

With 99% of S&P 500 Index companies having reported earnings for the first quarter (February, March, and April quarters), the index’s profits are on pace to grow 5%, down slightly from the 6% growth seen in the fourth quarter of 2012. In both quarters, growth came in more than three percentage points higher than the consensus projected a couple weeks before earnings season

Read More from the Hotline

Stock Spotlight

At Varian, X-ray marks the spot

Wednesday, June 5, 2013

Varian Medical Systems ($67; VAR) supplies X-ray tubes that help doctors identify cancerous areas and oncology systems that beam radiation to treat the ...

Read More from Stock Spotlight

Individual Stock Reports

ISRs make stock research easy!

Perhaps the most valuable two page reports available anywhere.

All the data you would normally have to plow through years of 10-K filings, earnings reports, and reams of market data to assemble — yours all in one concise report.

ISRs contain our proprietary Quadrix scores — find out how we rate all the stocks in the S&P 500.

Visit us at individualstockreports.com